A comprehensive view of gsk group (glaxosmithkline). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Fitch affirms GlaxoSmithKline's A- long-term issuer default rating with stable outlook, driven by strong diversification, improving profitability and free cash flow; financial flexibility expected to improve after split of its consumer-health division
Published: June 23, 2022 by ENP Newswire
“Chelating Platform For Delivery Of Radionuclides” In Patent Application Approval Process (USPTO 20220160904)
Published: June 14, 2022 by Cancer Daily
Glaxosmithkline Biologicals Files United States Patent Application For Novel Influenza Antigens
Published: June 14, 2022 by Pharmaceutical Patent News
GlaxoSmithKline to acquire Affinivax for US$2.1B and its bacterial infectious disease vaccine under development that targets 24 species of Streptococcus pneumoniae; pneumococcal vaccine market projected to grow to US$10B by 2028
Published: June 10, 2022 by Chemie Aktuell (CBNB Abstracts)
Gsk Announces Positive Phase Iii Data For Rsv Vaccine Candidate For Older Adults
Published: June 10, 2022 by CE Noticias Financieras (Latin America)

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count